These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21298731)

  • 21. Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK.
    Pollock RF; Muduma G
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1439-1446. PubMed ID: 29032713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.
    Hörl WH
    Perit Dial Int; 2001; 21(5):527-8. PubMed ID: 11757843
    [No Abstract]   [Full Text] [Related]  

  • 23. Ferumoxytol: an intravenous iron, riskier than iron sucrose.
    Prescrire Int; 2013 Sep; 22(141):206. PubMed ID: 24171212
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Total Dose Infusion of Iron Intravenously in Patients With Acute Heart Failure and Anemia (Hemoglobin < 13 g/dl).
    Kaminsky BM; Pogue KT; Hanigan S; Koelling TM; Dorsch MP
    Am J Cardiol; 2016 Jun; 117(12):1942-6. PubMed ID: 27161817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous iron products.
    Johnson CA; Mason NA; Bailie GR
    ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral or intravenous iron for anemia correction in chronic kidney disease?
    Drüeke TB; Massy ZA
    Kidney Int; 2015 Oct; 88(4):673-5. PubMed ID: 26422625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
    Mehta BC
    J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
    [No Abstract]   [Full Text] [Related]  

  • 29. Anemia and heart failure a new pathway?
    Francis GS; Kanderian A
    J Am Coll Cardiol; 2007 Oct; 50(17):1666-7. PubMed ID: 17950148
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic kidney disease: Serious adverse effects associated with IV iron in CKD.
    Allison SJ
    Nat Rev Nephrol; 2015 Sep; 11(9):506. PubMed ID: 26149838
    [No Abstract]   [Full Text] [Related]  

  • 31. Intravenous iron polymaltose complex for treatment of iron deficiency anaemia in pregnancy resistant to oral iron therapy.
    Singh K; Fong YF
    Eur J Haematol; 2000 Apr; 64(4):272-4. PubMed ID: 10776700
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
    Kochhar PK; Kaundal A; Ghosh P
    J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of different doses and types of intravenous iron on oxidative stress and inflammation in hemodialysis patients.
    Kumbasar A; Gursu M; Kaya C; Ozturk S; Ergen A; Kemik A; Aydin Z; Uzun S; Karadag S; Kazancioglu R
    J Nephrol; 2012; 25(5):825-32. PubMed ID: 22307439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
    Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
    Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome?
    Soufras GD; Kounis GN; Kounis NG
    Indian J Pharmacol; 2013; 45(6):642-3. PubMed ID: 24347784
    [No Abstract]   [Full Text] [Related]  

  • 37. Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran?
    Sav T; Tokgoz B; Sipahioglu MH; Deveci M; Sari I; Oymak O; Utas C
    Ren Fail; 2007; 29(4):423-6. PubMed ID: 17497463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of intravenous and oral iron in chronic kidney disease.
    Agarwal R; Kusek JW; Pappas MK
    Kidney Int; 2015 Oct; 88(4):905-14. PubMed ID: 26083656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia].
    Cançado RD; Brasil SA; Noronha TG; Chiattone CS
    Rev Assoc Med Bras (1992); 2005; 51(6):323-8. PubMed ID: 16444338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.